Research Topics
| D C HodgsonSummaryAffiliation: University of Toronto Country: Canada Publications
| Collaborators
|
Detail Information
Publications
A multi-institutional study of factors influencing the use of stereotactic radiosurgery for brain metastasesDavid C Hodgson
Radiation Medicine Program, Princess Margaret Hospital, University Health Network, and Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
Int J Radiat Oncol Biol Phys 85:335-40. 2013..We evaluated the extent to which local availability of SRS affected the treatment of patients with brain metastases...
Navigator channel adaptation to reconstruct three dimensional heart volumes from two dimensional radiotherapy planning dataAngela Ng
Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada
BMC Med Phys 12:1. 2012..abstract:..- A national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in CanadaEman Z Alduhaiby
Department of Radiation Oncology, University of Toronto, Canada
Radiat Oncol 7:18. 2012..Relatively little is known regarding the rate at which new RT technologies are adopted in different jurisdictions, and the barriers to implementation of these technologies... 
A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer riskEng Siew Koh
University of Toronto, Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
Radiat Oncol 2:13. 2007....- Factors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, CanadaKate Bak
Cancer Services and Policy Research Unit, Cancer Care Ontario, 620 University Avenue, Toronto, M5G 2L7, Canada
BMC Health Serv Res 11:178. 2011..This study examines the key steps in the process of adopting and implementing intensity modulated radiation therapy (IMRT) in publicly funded cancer centres and identifies facilitating or impeding factors... - Disseminating a smoking cessation intervention to childhood and young adult cancer survivors: baseline characteristics and study design of the partnership for health-2 studyJanet S de Moor
Division of Health Behavior and Health Promotion, The Ohio State University College of Public Health, Columbus, OH, USA
BMC Cancer 11:165. 2011..Partnership for Health-2 (PFH-2) is a web-based version of Partnership for Health, an evidence-based smoking cessation intervention for childhood cancer survivors. This paper describes the PFH-2 intervention and baseline data collection... 
The impact of irregularly rising prostate-specific antigen and "impending failure" on the apparent outcome of localized prostate cancer following radiotherapyD C Hodgson
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Int J Radiat Oncol Biol Phys 49:957-63. 2001..To examine the impact of irregularly rising prostate-specific antigen (PSA) and "impending" biochemical failure on the apparent rate of biochemical relapse following radiotherapy for localized prostate cancer...- Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphomaDavid C Hodgson
Princess Margaret Hospital, University Health Network, and the Department of Radiation Oncology, University of Toronto, Canada
J Clin Oncol 25:1489-97. 2007..However, no investigation has used multivariate modeling to estimate the relative risk (RR), excess absolute risk (EAR), and cumulative incidence for specific attained ages and ages at HL diagnosis... - Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicityDavid C Hodgson
Radiation Medicine Program, Princess Margaret Hospital, University Health Network, and Department of Radiation Oncology, University of Toronto, Toronto, Canada
Semin Radiat Oncol 17:230-42. 2007..The challenge is to refine therapy in a rare disease in which long-time intervals are necessary to observe an adequate number of events (treatment failure or late effects) to answer judicious questions... - Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphomaDavid C Hodgson
University of Toronto, Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
Cancer 110:2576-86. 2007..This study gives individualized estimates for the risks of lung and female breast cancer expected with contemporary involved-field RT and low-dose (20 Gy) RT for mediastinal Hodgkin lymphoma... - Hodgkin lymphoma: the follow-up of long-term survivorsDavid C Hodgson
Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, 610 University Avenue, Toronto M5G 2M9, Canada
Hematol Oncol Clin North Am 22:233-44, vi. 2008.... - A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effectsDavid C Hodgson
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Cancer 116:3417-25. 2010..The majority of Hodgkin lymphoma (HL) patients are cured, and post-treatment visits are a major component of their management. Little is known about the quality of follow-up care received by these survivors... - Late effects in the era of modern therapy for Hodgkin lymphomaDavid C Hodgson
Department of Radiation Oncology, University of Toronto, Toronto, ON
Hematology Am Soc Hematol Educ Program 2011:323-9. 2011.... - Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapyDavid C Hodgson
Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Canada
Hematol Oncol 25:11-5. 2007..Female HL patients who had survived without recurrence > or =3 years and who had attempted pregnancy after ABVD did not experience significant sub-fertility... - The consistency of panelists' appropriateness ratings: do experts produce clinically logical scores for rectal cancer treatment?David C Hodgson
Department of Radiation Oncology, Princess Margaret Hospital, 610 University Ave, Toronto, Ont, Canada M5G 2M9
Health Policy 71:57-65. 2005..To quantify the clinical consistency of expert panelists' ratings of appropriateness of pre-operative and post-operative chemotherapy plus radiation for rectal cancer... - Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapyDavid C Hodgson
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
Int J Radiat Oncol Biol Phys 57:1374-81. 2003..To examine the impact of extranodal chest wall and lung invasion on the prognosis of patients with clinical Stage I-II Hodgkin's lymphoma treated with combined modality therapy... - Evolution of treatment for Hodgkin's disease: a population-based study of radiation therapy use and outcomeD C Hodgson
The Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
Clin Oncol (R Coll Radiol) 15:255-63. 2003..To examine changes in radiotherapy (RT) use, cause-specific survival (CSS), and overall survival (OS) in a population-based cohort of Hodgkin's disease (HD) patients diagnosed from 1982 to 1996... - Stage I and II MALT lymphoma: results of treatment with radiotherapyR W Tsang
Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
Int J Radiat Oncol Biol Phys 50:1258-64. 2001..We analyzed our recent experience with Stage I/II MALT lymphoma presenting in the stomach and other organs to assess the outcome following involved field radiation therapy (RT)... - Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphomaEng-Siew Koh
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Int J Radiat Oncol Biol Phys 66:223-8. 2006.... - Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiationLionel M L Chow
Division of Haematology and Oncology, Department of Paediatrics, Toronto Sunnybrook Regional Cancer Centre, The Hospital for Sick Children, Toronto, Ontario, Canada
J Clin Oncol 24:5735-41. 2006.... - Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcomeR W Tsang
Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, 610 University Avenue, Toronto, Ontario, M5G 2M9 Canada
Int J Radiat Oncol Biol Phys 50:113-20. 2001..In this study, we attempt to identify factors that predict for local failure, progression to multiple myeloma, and disease-free survival (DFS) in patients mainly managed with local RT... - Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapySten Myrehaug
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Leuk Lymphoma 49:1486-93. 2008..These results suggest that the risk of clinically important cardiac toxicity following HL treatment that includes both doxorubicin and mediastinal RT may be greater than that reported in prior studies of patients treated with RT alone... - Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapyJayant S Goda
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Cancer 116:3815-24. 2010..This study was conducted to evaluate the long-term outcomes in patients with stage IE and IIE mucosa-associated lymphoid tissue (MALT) lymphomas treated with involved field radiotherapy (RT)... - Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcomeRichard W Tsang
Department of Radiation Oncology and Biostatistics, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
J Clin Oncol 21:4157-64. 2003..We report the clinical outcome of stage I and II MALT lymphoma treated with involved field radiation therapy (RT)... - Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomesKim Edelstein
Psychosocial Oncology and Palliative Care, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada
Neuro Oncol 13:536-45. 2011..It will become increasingly important to identify factors that contribute to risk and resilience in this growing population... - Therapy of non-Hodgkin's lymphomaJ Coffey
Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
Eur J Nucl Med Mol Imaging 30:S28-36. 2003..The management of MALT lymphomas, especially gastric MALT lymphoma, deserves special attention because of the high response rate to Helicobacter pylori eradication therapy... - A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart diseaseSten Myrehaug
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada
Blood 116:2237-40. 2010.... - Relation of hospital volume to colostomy rates and survival for patients with rectal cancerDavid C Hodgson
Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
J Natl Cancer Inst 95:708-16. 2003..Identifying processes of care that contribute to these differences may improve patients' outcomes in all hospitals... - Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effectsAngela Punnett
Division of Hematology and Oncology, Hospital for Sick Children, Toronto, ON, Canada
Semin Radiat Oncol 20:30-44. 2010..Novel approaches to prognostic stratification and therapy on the basis of these differences may be necessary to maximize cure and minimize late effects across the ages... - Radiosurgery in the management of pediatric brain tumorsD C Hodgson
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Canada
Int J Radiat Oncol Biol Phys 50:929-35. 2001..Some patients with unresectable relapsed disease can be salvaged with SRS. SRS to multiple lesions does not appear to be curative. Serious neurologic symptoms requiring reoperation is infrequently caused by radionecrosis alone... - Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancerD C Hodgson
D. C. Hodgson, Department of Radiation Oncology, Princess Margaret Hospital and Institute for Clinical Evaluative Sciences, University of Toronto, ON, Canada
J Natl Cancer Inst 93:501-15. 2001..To improve quality of care for colorectal cancer, a better understanding of mechanisms underlying associations between patient and provider characteristics and outcomes is required... - Reconstruction of 3D lung models from 2D planning data sets for Hodgkin's lymphoma patients using combined deformable image registration and navigator channelsAngela Ng
Radiation Medicine Program, Princess Margaret Hospital, University Health Network, Toronto, Ontario M5G 2M9, Canada
Med Phys 37:1017-28. 2010.... - Error in the delivery of radiation therapy: results of a quality assurance reviewGrace Huang
Radiation Medicine Program, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
Int J Radiat Oncol Biol Phys 61:1590-5. 2005..The introduction of new technology can produce new ways for errors to occur, necessitating ongoing evaluation of RT errors for quality assurance. Modifications to processes of care can produce important reductions in error rates... - Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphomaChandra Martens
Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada
Int J Radiat Oncol Biol Phys 64:1183-7. 2006..CONCLUSION: Hyperfractionated RT provided good local control and was well tolerated. This encouraging result requires additional study with comparison to conventional fractionation regimens... - Hodgkin's lymphomaRichard W Tsang
Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
Curr Probl Cancer 30:107-58. 2006 - Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology GroupSadhna M Shankar
Division of Pediatric Hematology Oncology, Department of Pediatrics, Vanderbilt University, Nashville, Tennessee 37232 6310, USA
Pediatrics 121:e387-96. 2008.... - Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patientsSara J Schonfeld
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-7238, USA
J Natl Cancer Inst 98:215-8. 2006..The EAR of AML declined statistically significantly after 1984 (7.0 to 4.2 and 16.4 to 9.9 in the < 35 and > or = 35 age groups, respectively), which may be associated with modifications in chemotherapy...